65 studies found for:    CONCERT
Show Display Options
Rank Status Study
1 Terminated An Extension of the CONCERT Protocol (DIM18)
Condition: Alzheimer's Disease
Intervention: Drug: Dimebon
2 Completed Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo comparator
3 Recruiting Congenital Cytomegalovirus: Efficacy of Antiviral Treatment
Conditions: Congenital Cytomegalovirus Infection;   Sensorineural Hearing Loss
Intervention: Drug: Valganciclovir
4 Completed A Clinical Trial Of Two Educational Strategies In Cardiovascular Health In Child Population
Conditions: Obesity;   Cardiovascular Diseases
Intervention: Other: Didactic Concerts
5 Completed
Has Results
Observation of Patients With Metastatic Colorectal Cancer Starting Chemotherapy Combined With Bevacizumab (Avastin)
Condition: Metastatic Colorectal Cancer
Interventions: Other: Observational Chemotherapy;   Drug: Concomitant Bevacizumab
6 Terminated Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial
Conditions: Congenital Cytomegalovirus Infection;   Sensorineural Hearing Loss
Intervention: Drug: Valganciclovir
7 Recruiting Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure
Condition: Ischemic Cardiomyopathy
Interventions: Biological: Mesenchymal Stem Cells (MSC);   Biological: Cardiac Stem Cells (CSC);   Biological: Placebo (Plasmalyte A)
8 Not yet recruiting Pairing Functional Electrical Stimulation (FES) and Volitional Effort Training Promotes Neuroplasticity and Motor Gain
Conditions: Stroke;   Drop Foot
Interventions: Other: FES + VOL;   Other: FES;   Other: VOL
9 Recruiting Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach
Conditions: Unilateral Acoustic Neuroma;   Meniere's Disease
Intervention: Device: Cochlear Implant
10 Recruiting Cochlear Implantation in Cases of Single-Sided Deafness
Conditions: Unilateral Moderate to Profound Hearing Loss, Single-Sided Deafness (SSD);   Asymmetric Hearing Loss
Interventions: Device: Cochlear Implant;   Other: Control Group
11 Completed Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma
Conditions: Brain Tumors;   Central Nervous System Tumors
Interventions: Drug: cyclosporine;   Drug: etoposide;   Drug: vincristine sulfate;   Radiation: radiation therapy
12 Completed A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and Pharmacodynamics
Condition: Narcolepsy, Excessive Daytime Sleepiness
Interventions: Drug: Placebo;   Drug: Sodium Oxybate;   Drug: JZP-386
13 Completed A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Conditions: Type 2 Diabetes Mellitus;   Chronic Kidney Disease
Interventions: Drug: CTP-499;   Drug: Placebo
14 Completed Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney Disease
Condition: Stage 3 Chronic Kidney Disease
Interventions: Drug: CTP-499;   Drug: placebo
15 Recruiting Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CTP-543 in Healthy Subjects
Condition: Healthy
Interventions: Drug: CTP-543;   Drug: Placebo for CTP-543
16 Completed Food Effect Study of CTP-656 in Healthy Male Volunteers
Condition: Healthy
Intervention: Drug: CTP-656
17 Completed Healthy Volunteer Solid Oral Dose and Multiple Ascending Dose Evaluation of CTP-656
Condition: Healthy
Interventions: Drug: CTP-656;   Drug: Placebo for CTP-656;   Drug: Kalydeco
18 Completed Multiple Ascending Dose Study in Healthy Volunteers
Condition: Healthy
Interventions: Drug: CTP-730;   Drug: Placebo for CTP-730
19 Completed Study to Evaluate Safety, Tolerability and PK of C-10355 and C-10358 in Healthy Subjects
Condition: Healthy
Interventions: Drug: C-10355;   Drug: C-10358;   Drug: Kalydeco
20 Completed A Safety and Tolerability Study of CTP-730 in Healthy Volunteers
Condition: Healthy
Interventions: Drug: CTP-730;   Drug: Placebo for CTP-730

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years